Behavioral tests show that 5HT2C receptor antagonists decrease anxiety-like behavior in zebrafish, suggesting potential therapeutic avenues.
The present study aims to describe the acute effects of 5-HT 2C receptor agonists and antagonists in behavioral tests related to anxiety in adult zebrafish ( Danio rerio ). For this, three groups of fish ( n = 12/group) were used: a group treated with the drug MK-212 (2 mg/kg), a 5-HT 2C receptor agonist; another group treated with the drug RS-102221 (2 mg/kg), a 5-HT 2C receptor antagonist; and a third group, the control group, using a vehicle solution. The three groups were exposed to two behavioral tests: novel tank test (NTT) and light-dark preference (LDT). MK-212 produced no effects on the NTT, while RS-102221 decreased geotaxis (d = 0.99, 95%CI[0.3, 1.7]) and erratic swimming (d = 0.87, 95%CI[0.18, 1.56]) in this test; these effects are consistent with a tonic facilitation of defensive behavior in the NTT. Conversely, in the LDT, MK-212 increased scototaxis (d = 0.96, 95%CI[0.25, 1.65]), risk assessment (d = -1.31, 95%CI[-2.02, -0.59]), and thigmotaxis (d = -1.48, 95%CI[-2.21, -0.75]), consistent with an anxiogenic-like effect of this drug. Thus, tonic and phasic effects of the activation of this receptor are observed depending on the type of behavioral test used.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: